| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 16, 2026 | GHIT Fund Launches "NTDpedia" to Help Turn Apathy Into Action Against Neglected Tropical Diseases | The interactive educational website makes NTDs understandable
to a general audience, the first step toward public support that drives R&D
for the 1.5 billion people affected by these diseases
TOKYO, Sept. 16, 2026 /PRNewswire/ -- The Gl... |
| Jul 23, 2026 | GHIT Fund Invests Approx. JPY 140 Million in a Portable Rapid Diagnostic System for Ebola Disease in a Joint Project Between Osaka Metropolitan University, K.K. DNAFORM, and INRB | TOKYO, July 23, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of JPY 140 million (approximately USD 862,000) in a project to develop a portable rapid diagnostic system for Ebola disea... |
| Apr 22, 2026 | Total Investment of Approx. USD 8.5 Million in Malaria and NTD R&D Projects With Partners Including MMV, GSK, Tanabe Pharma, Eisai and DNDi | TOKYO, April 22, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.37 billion (USD 8.5 million1) in five R&D projects for the development of drugs for mala... |
| Feb 3, 2026 | Total Investment of Approx. USD 8.8 Million in Malaria, Tuberculosis, and NTD R&D Projects with Partners Including Mahidol University, Barcelona Institute for Global Health, and Eisai | TOKYO, Feb. 3, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.39 billion (USD 8.8 million1) in six R&D projects for the development of drugs, diagnostic... |
| Dec 8, 2025 | Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others | TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 70 million (USD 460,0001) for the development of a prototype detection test for mpox (formerly known ... |
| Oct 29, 2025 | Total Investment of Approx. USD 11.6 Million in TB and NTD R&D Projects With Partners Including Fujifilm, Stop TB Partnership, and the Ohio State University | TOKYO, Oct. 29, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.73 billion (USD 11.6 million1) in four R&D projects for the development of diagnostics an... |
| Aug 27, 2025 | ExpreS2ion Biotech Announces Analysguiden Publishes Updated Equity Research Report; Price Target Maintained at SEK 75 | ExpreS2ion Biotech Announces Analysguiden Publishes Updated Equity Research Report; Price Target Maintained at SEK 75
Wed, Aug 27, 2025 15:15 CET Report this content
Hørsholm, Denmark, 27 August 2025 – ExpreS2ion Biotech Holding AB’s affili... |
| Aug 21, 2025 | ExpreS2ion Announces Financial Results for the First Half and Second Quarter of 2025 | ExpreS2ion Announces Financial Results for the First Half and Second Quarter of 2025
Thu, Aug 21, 2025 08:30 CET Report this content
Hørsholm, Denmark, 21 August 2025 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces its half-y... |
| Jul 18, 2025 | ExpreS2ion Highlights Strategic Relevance of GHIT-Funded Malaria Vaccine Development Through Ownership in AdaptVac | ExpreS2ion Highlights Strategic Relevance of GHIT-Funded Malaria Vaccine Development Through Ownership in AdaptVac
Fri, Jul 18, 2025 11:50 CET Report this content
Hørsholm, Denmark, 18 July 2025 - ExpreS2ion Biotech Holding AB (Nasdaq First... |
| Jul 17, 2025 | Total Investment of Approx. USD 7.3 Million in Malaria and TB R&D Projects With Partners Including European Vaccine Initiative, University of Copenhagen, and University of Tübingen | TOKYO, July 17, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1 billion (USD 7.3 million1) in four R&D projects for the development of vaccine, drug, and... |
| Apr 23, 2025 | Investment of Approx. USD 4.5 Million in Development of Diagnostics for Tuberculosis to Partners Including Fujirebio and University Hospital Heidelberg | TOKYO, April 23, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 679 million (USD 4.5 million1) for the development of diagnostics for tuberculosis, in addition to ... |
| Mar 18, 2025 | Total Investment of Approx. USD 11.4 Million in Schistosomiasis Diagnostics and R&D Projects for NTDs With Partners Including Drugs & Diagnostics for Tropical Diseases and Medical & Biological Laboratories | TOKYO, March 18, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.7 billion (USD 11.4 million1) in five projects for the development of schistosomiasis diagno... |
| Mar 5, 2025 | GHIT-backed Innovation Achieves Landmark: New Treatment Option for Schistosomiasis Reaches Preschool-Aged Children | TOKYO, March 5, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund is today announcing a significant milestone: the first administration of arpraziquantel to preschool-aged children in Uganda, in an implementation scie... |
| Jan 30, 2025 | A Total of USD 12.7 Million Investment in New Diagnostics and Drug Development for NTDs and Malaria to Partners Including the Ohio State University, PATH, GSK and Others | TOKYO, Jan. 30, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 2 billion (USD 12.7 million1) in eight projects for the development of new diagnostics and drug... |
| Dec 12, 2024 | Bridging the Gap: Financial Inclusion and Global Health Initiatives | In a world where financial barriers often dictate the quality of life, the recent funding success of Avanti Finance shines a light on the path to financial inclusion. This Bengaluru-based company has raised $14.2 million in a Series B1B2 fu... |
| Dec 11, 2024 | Partnership Established to Advance WHO's Road Map for Neglected Tropical Diseases 2021-2030 | TOKYO and GENEVA, Dec. 11, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund and the World Health Organization (WHO) have signed a memorandum of understanding (MoU) to further expand their partnership to promote acces... |
| Nov 19, 2024 | GHIT Fund Awarded Open Philanthropy Grant to Expand Funding Sources for Global Health R&D | TOKYO, Nov. 19, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund is pleased to announce that Open Philanthropy, a grantmaking organization based in San Francisco, California, has awarded funding for efforts to cultiv... |
| Nov 12, 2024 | New Guidelines and Investments: A Dual Approach to Combat Health Threats | Stroke is a silent predator. It strikes swiftly, often without warning. The latest guidelines from health authorities aim to arm the public with knowledge and tools to fend off this fourth leading cause of death in the United States. Meanwh... |
| Nov 12, 2024 | The Unsung Heroes of Cleanliness: A Deep Dive into the Challenges Faced by Janitors in Office Cleaning Services | Janitors are the silent sentinels of cleanliness in our bustling office environments. They work tirelessly behind the scenes, ensuring that every corner is spotless and every surface is sanitized. Yet, their contributions often go unnoticed... |
| Nov 7, 2024 | Approx. USD 4.0 M Invested in Product Development for NTDs - GHIT's First Investment in the Development of Diagnostics for Trachoma | TOKYO, Nov. 7, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 578 million (USD 4.0 million1) in four projects for the development of new diagnostics and drugs... |
| Sep 19, 2024 | Dr. Quarraisha Abdool Karim, Hideyo Noguchi Africa Prize Winner, Joins GHIT Fund Board of Directors | First Board Member from Africa
TOKYO, Sept. 19, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund is pleased to announce that Dr. Quarraisha Abdool Karim was elected and appointed to the Director of the GHIT Fund Boar... |
| May 9, 2024 | Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions | TOKYO, May 9, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects for the development of new drugs for malaria an... |
| Apr 26, 2024 | Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa | SHANGHAI, April 26, 2024 /PRNewswire/ -- World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO ... |
| Mar 25, 2024 | Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB | AUD 17 Million Grant over 5 Years Will Fund Next-Generation TB Cures
CANBERRA, Australia, March 25, 2024 /PRNewswire/ -- The Australian Government, through the Partnerships for a Healthy Region initiative, has announced a new AUD 17 million... |
| Nov 15, 2023 | 栄研化学株式会社がGHIT Fundの新規スポンサーとして参画 | 公益社団法人グローバルヘルス技術振興基金（以下、GHIT Fund）は、臨床検査薬のパイオニアである栄研化学株式会社（代表執行役社長：納富 継宣、本社：東京都台東区）が新規スポンサーとして参画したことを発表いたします。
GHIT Fund CEO である國井修は次のように述べています。「GHIT Fundの第3次5カ年計画『GHIT3.0』に賛同いただき、製品開発への参加だけでなく、新規スポンサーとして資金面でもご支援をいただけることとなり、大変嬉しく思います。栄研化学が有... |
| Oct 12, 2023 | グローバルヘルス技術振興基金とダカール・パスツール研究所、低中所得国の診断薬とワクチンの研究開発に対する連携強化の覚書を締結 | 公益社団法人グローバルヘルス技術振興基金（以下、GHIT Fund）とセネガルの非営利財団であるダカール・パスツール研究所（Institut Pasteur de Dakar：以下、IPD）は、低中所得国（LMICs）における感染症の診断薬およびワクチンの研究開発に対する連携強化の覚書を締結したことを発表します。
GHIT Fund 副会長 ピーター・ピオット（左）、ダカール・パスツール研究所CEO アマドゥー・アルファ・サル（右）
GHIT Fundは結核、マラリア、顧... |
| Mar 30, 2023 | A Total of Approximately 400 Million Yen Investment in Eisai, Ehime University, DNDi and Others for New Drug and Vaccine Development for Neglected Tropical Diseases | TOKYO, March 30, 2023 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment totaling approximately 400 million yen (US$2.9 million1) for the research and development of new drugs against mycetoma ... |
| Jan 23, 2023 | The European Medicines Agency (EMA) Validated Regulatory Application for Arpraziquantel, a Potential Treatment for Schistosomiasis in Preschool-Aged Children | Arpraziquantel is the first investigational drug in regulatory phase amongst the different projects supported by the GHIT (Global Health Innovative Technology) Fund. GHIT Fund has financed the clinical development of the Pediatric Praziquan... |
| Mar 31, 2021 | CHUGAI PHARMACEUTICAL CO., LTD.
Chugai Pharmaceutical : Organizes the Second Workshop on Multidisciplinary Team Care Online for Healthcare Professionals in Cambodia | Chugai Organizes the Second Workshop on Multidisciplinary Team Care
Online for Healthcare Professionals in Cambodia
17 medical professionals in Cambodia participated in the second workshop on multidisciplinary team care in collaboration wit... |
| Jul 23, 2019 | Japanese Foreign Minister’s Commendations for FY 2019 to Dr. Slingsby, Founder & Managing Partner of Catalys Pacific | Foreign Minister’s Commendations are awarded to individuals and groups with outstanding achievements in international fields to acknowledge their contributions to the promotion of friendship between Japan and other countries and areas. The ... |
